Stablepoint Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Stablepoint Partners's MDT Position: Q3 2026 in Review
Stablepoint Partners increased its Medtronic (MDT) stake by 17% in Q3 2026, buying an estimated $1.11M and bringing the position to 86,771 shares worth $7.49M. The position accounts for 1.01% of the portfolio, ranked #29.
Stablepoint Partners first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. 2,200 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Stablepoint Partners held 86,771 shares of Medtronic worth $7.49M as of Q3 2026.
- Stablepoint Partners bought 12,582 Medtronic shares in Q3 2026, an estimated $1.11M.
- Medtronic made up 1.01% of Stablepoint Partners's portfolio in Q3 2026, its #29 holding.
- Stablepoint Partners first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
- 2,200 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Stablepoint Partners's 13F filing for Q3 2026, filed 3 Nov 2026.